Security key
G1933S101
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 1,322,529
- Total 13F value
- $8,138,853
- Share change
- +970,359
- Put/Call ratio
- 350%
- SEC-reported price per share
- $6.16
- Number of holders
- 20
- Value change
- +$5,984,886
- Number of buys
- 6
- Number of sells
- 7
- Shares outstanding
- 40,791,726
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
20
Top holders
10
CASIF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
CASI Pharmaceuticals, Inc. SEC filings
CASI Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G1933S101
Recent filing periods:
Ownership snapshot
Top reported holders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 0.27%
Showing 1-6 of 15 holder rows.
Quick read
Venrock Adviser, LLC leads the comparable SEC ownership view at 0.27%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership
Top 5
Venrock Adviser, LLC
0.27%
Wellington Shields Capital Manage...
0.22%
Wellington Shields & Co., LLC
0.11%
RENAISSANCE TECHNOLOGIES LLC
0.1%
GEODE CAPITAL MANAGEMENT, LLC
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Adviser, LLC |
13F
Company
|
0.27%
|
$614,273
111,686 shares
|
— | 30 Jun 2024 |
| Wellington Shields Capital Management, LLC |
13F
Company
|
0.22%
|
$490,694
89,217 shares
|
— | 30 Jun 2024 |
| Wellington Shields & Co., LLC |
13F
Company
|
0.11%
|
$237,001
43,091 shares
|
— | 30 Jun 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.1%
|
$224,400
40,800 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.05%
|
$122,215
22,221 shares
|
— | 30 Jun 2024 |
| HOWLAND CAPITAL MANAGEMENT LLC |
13F
Company
|
0.04%
|
$82,896
15,072 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
20
Shares
1,322,529
Rows available
20
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
23
Q3 2024 holders
20
Holder diff
-3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend